Health Canada Approves Integrated Mapping and Pulsed Field Ablation System for AF

By HospiMedica International staff writers
Posted on 13 Aug 2026

Electrophysiology teams continue to refine catheter ablation strategies for atrial fibrillation (AF), emphasizing efficient workflows and real-time guidance. Combining high-density (HD) cardiac mapping with ablation supports personalized treatment strategies and pulmonary vein isolation. An integrated approach using a single catheter can enable both single-shot pulmonary vein isolation and customizable, targeted ablation. A new system has launched that integrates high‑density mapping with pulsed field ablation to deliver these capabilities.

Image: The Globe mapping and ablation catheter from Kardium (Photo courtesy of Kardium Inc)

Kardium Inc. has received a Medical Device Licence from Health Canada for the Globe Pulsed Field System, expanding access to its integrated mapping and pulsed field ablation platform. The authorization follows the system’s U.S. launch after receiving U.S. Food and Drug Administration (FDA) approval in 2025. Developed in Canada, the system is intended for the treatment of atrial fibrillation (AF).

The Globe Pulsed Field System combines a 122-electrode spherical array, real-time thermal contact sensing, and advanced visualization tools. It is described as the only integrated high-density cardiac mapping and ablation system that enables both single-shot pulmonary vein isolation and customizable, targeted ablation with a single catheter. These capabilities are designed to support personalized treatment strategies while streamlining AF ablation workflows.

Clinical data from the pivotal PULSAR study demonstrated the system’s safety and effectiveness in patients with paroxysmal AF. At one year, 78% of patients remained free from atrial arrhythmia, with no device-related primary safety events reported. The findings support the system as a durable, safe, and effective approach to AF treatment.

"Health Canada approval represents another important milestone for Kardium and is especially meaningful as a Canadian based company. Following the successful introduction of the Globe System in the United States, we are excited to bring this innovative technology to physicians and patients in Canada. The Globe System reflects our commitment to developing a better way to treat AF through a personalized, efficient, and effective treatment," said Kevin Chaplin, CEO of Kardium.

"The Globe System represents an important step forward in AF ablation. By combining HD mapping and ablation together in a single platform, the system provides physicians with more confidence in delivering a durable and effective treatment for patients," said Dr. Atul Verma of McGill University in Montreal.

Other channels

Health Canada Approves Integrated Mapping and Pulsed Field Ablation System for AF

Latest Surgical Techniques News

Other channels